Notably, overexpression of TOX was found to have adverse prognostic implications in cutaneous T-cell lymphomas (CTCL), where it correlated with disease progression and mortality [16]. Here, TOX is linked to primary cutaneous T-cell non-Hodgkin lymphoma.